Browsing by Author Mihaylova, Borislava

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2016Cost-effectiveness of simvastatin plus ezetimibe for cardiovascular prevention in CKD: Results of the study of heart and renal protection (SHARP)Craig, Jonathan; Cass, Alan; Emberson, Jonathan; et al, Various; Haynes, Richard; Herrington, William; Kent, Seamus; Lozano-Kuhne, Jingky; Mihaylova, Borislava; Reith, Christina; Schlackow, Iryna; School of Public Health: Public HealthCost-effectiveness of simvastatin plus ezetimibe for cardiovascular prevention in CKD: Results of the study of heart and renal protection (SHARP), American Journal of Kidney Diseases, vol.67, 4, 2016,pp 576-584
2012The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trialsKeech, Anthony (Tony); Simes, Robert John; Baigent, C; Barnes, Elizabeth; Blackwell, L; Braunwald, Eugene; Collins, Rory; de Lemos, James A; Emberson, Jonathan; et al, Various; Gray, Alastair; Mihaylova, Borislava; Voysey, M; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreThe effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials, The Lancet, vol.380, 9841, 2012,pp 581-590
2015Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trialsKeech, Anthony (Tony); Kirby, Adrienne; O'Connell, Rachel; Blackwell, Lisa; Braunwald, Eugene; Colhoun, Helen; Collins, Rory; Emberson, Jonathan; et al, Various; Fulcher, Jordan; La Rosa, John; Mihaylova, Borislava; Simes, John; Voysey, Merryn; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreEfficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trials, The Lancet, vol.385, 9976, 2015,pp 1397-1405
2016Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKDMorton, Rachael; Baigent, C; Cass, Alan; Emberson, Jonathan; Gray, Alistair; Haynes, Richard; Herrington, William; Landray, Martin J.; Mihaylova, Borislava; Schlackow, Iryna; Staplin, Natalie D; NH&MRC Clinical Trials CentreImpact of Educational Attainment on Health Outcomes in Moderate to Severe CKD, American Journal of Kidney Diseases, vol.67, 1, 2016,pp 31-39
2016The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic reviewMorton, Rachael; Cass, Alan; Gray, Alastair; Mihaylova, Borislava; Schlackow, Iryna; Staplin, Natalie D; NH&MRC Clinical Trials CentreThe impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review, Nephrology, Dialysis, Transplantation, vol.31, 1, 2016,pp 46-56
2015What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?Cass, Alan; Baigent, C; Emberson, Jonathan; Gray, Alastair; Haynes, Richard; Herrington, William; Kent, Seamus; Landray, Martin J.; Lozano-Kuhne, Jingky; Mihaylova, Borislava; Reith, Christiana; Schlackow, Iryna; School of Public Health: MedicineWhat is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?, BMC Nephrology, vol.16, 1, 2015,pp 1-8